Advertisement
Home Tags Diabetes: Misc.

Tag: Diabetes: Misc.

Continuous glucose monitors are recommended for adults with type 1 diabetes

Continuous Glucose Monitors Recommended in T1DM

Strongest recommendation for adults with type 1 diabetes who are willing and able to use monitors
The first automated insulin delivery device for type 1 diabetes has been approved by the U.S. Food and Drug Administration for patients aged 14 and older.

FDA Approves ‘Artificial Pancreas’ for Type 1 Diabetes

MiniMed 670G hybrid closed loop system automatically monitors glucose, delivers insulin
For patients with critical limb ischemia

Diabetes Ups Risk of Amputation in Critical Limb Ischemia

Unadjusted hazard ratio of diabetes mellitus 1.87 for major amputation risk in critical limb ischemia
Diabetes is more widespread among descendants of Canada's First Nations people than among the general population

Diabetes Risk Higher in Canada’s First Nations People

Eight of 10 will develop diabetes, and decades sooner than others
Patients with diabetes often have fractures

Sitagliptin Not Linked to Higher Fracture Risk in Diabetes

Findings from TECOS trial show increased and decreased fracture risk with insulin, metformin
Nearly all middle-aged patients with diabetes should be taking statins

Too Few Diabetes Patients Receiving Statins

Two in five middle-aged patients don't get the medications, despite recommendations to do so
Glycemic index values of the same foods can vary widely and may be an unreliable indicator of blood glucose response

Glycemic Index Poor Indicator of Blood Glucose Response

Wide variability seen after eating same food at different times
Patients with type 1 diabetes have more diabetes-associated autoantibodies (DAAs) and non-DAAs than patients with type 2 diabetes

More Diabetes-Associated, Non-Associated Autoantibodies in T1D

Systemic immune mediators negatively correlated with diabetes-associated autoantibody titers
The adoption rate of the newest antidiabetes pharmacotherapy

Antidiabetes Prescriptions 15-Fold Higher Than Antiobesity Rx

Mean increase of 25,259 prescriptions per month for SGLT2s versus 5,154 for new antiobesity meds

August 2016 Briefing – Diabetes & Endocrinology

Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for August 2016. This roundup includes...